The PGY-2 Critical Care Residency at Baylor University Medical Center at Dallas is a one-year specialty program designed to provide the resident with exposure to a diverse population of critically ill patients. The primary emphasis of the residency is to develop well-rounded clinicians who can provide high level pharmaceutical care in a variety of ICU settings.
To accomplish this goal, the resident will function as an integral member of the critical care team in order to acquire practical clinical experience. Through patient data collection and analysis, the resident will develop the knowledge and skills to provide patient-specific and evidence-based pharmacotherapy, while functioning as an independent practitioner. In addition, valuable leadership and research skills are developed through participation in a critical care related interdisciplinary committees and completion of a clinical research project.
Medical Intensive Care (2 months)
Surgical-Trauma Intensive Care (2 months)
Neurosurgical Intensive Care
Cardiac Intensive Care
Cardiothoracic Surgery Intensive Care
Research Project: The resident is required to design, develop, and complete an original research project. The resident will present the project as a poster at ASHP's Mid-Year Clinical Meeting and as a platform presentation at ALCALDE Southwest Leadership Conference. A written manuscript of the research results is required to be submitted to the program director prior to completion of the program.
Seminar Presentation: The resident is required to prepare one 60-minute presentation for ACPE credit on an approved critical care topic.
Medication Use Evaluation: The resident is required to conduct an MUE on an approved critical care medication and present the finding to pharmacy and hospital leadership.
Precepting: Co-preceptor for pharmacy students and PGY1 pharmacy residents
Educational Lectures: Case presentations, journal clubs, inservices, formal and informal lectures
Staffing: Up to every 3rd weekend and one evening shift per month
Code Response: The resident attends and actively participates in code response throughout the residency year and co-precepts the PGY-1 residents in this setting.
Evaluations: The resident is expected to complete all evaluations via PharmaAcademic in a timely manner.
Licensure: The resident must obtain Texas pharmacy licensure no later than Sept. 1 of the residency year.
Jennifer Roth, PGY2 Residency Program Director, and Vivek Kataria, Current PGY2 Resident
Vivek Kataria, PharmD
PGY-2 Critical Care Resident
PGY-1 Pharmacy Practice Residency, Christiana Care Health System, Newark, DE
Doctor of Pharmacy, Philadelphia College of Pharmacy, Philadelphia, PA
Jennifer Roth, PharmD, BCPS, BCCCP
PGY2 Critical Care Residency Director
Clinical Pharmacist, Critical Care-Surgical/Trauma ICU
Baylor Scott & White Health - Dallas
3500 Gaston Ave.
Dallas, Texas 75246
PGY1 Pharmacy Practice Residency at Saint Luke’s Hospital, Kansas City MO
Doctor of Pharmacy, University of Missouri-Kansas City, Kansas City MO
PGY2 Critical Care Residency Program Director (Current)
Clinical Pharmacist, Critical Care-Surgical Trauma, Baylor University Medical Center at Dallas, Dallas TX
Clinical Pharmacist, Emergency Medicine, Baylor University Medical Center at Dallas, Dallas TX